The U.S. Food and Drug Administration (FDA) has approved a drug for treating patients with a rare form of neurological disease called amyotrophic lateral sclerosis (ALS). ALS affects motor neurons—nerve cells in the brain and spinal cord that control voluntary muscle movements like walking, chewing, breathing, and talking. An individual suffering from ALS loses the…

An abnormal protein known to cause rare genetic forms of motor neurone disease (MND) could be implicated in nerve cell death in all forms of the condition, Australian researchers have found. The study, led by researchers from the University of Sydney’s Brain and Mind Centre and published in the neuroscience journal “Brain,” is the first…